Skip to main content
. 2022 Oct 11;32(6):574–581. doi: 10.4103/ijn.IJN_591_20

Table 2.

Baseline biochemical parameters among three groups

Parameter Total (n=120)
Mean±SD/%
GROUP 1 (n=40)
Mean±SD/%
GROUP 2 (n=40)
Mean±SD/%
GROUP 3 (n=40) P
Mean±SD/%
Hb (gm%) 52.51±15.49 10.75±2.01 10.98±1.76 10.80±1.86 0.91
Blood Urea (mg/dl) 61.98±19.62 66.73±21.66 59.20±19.67 61.75±16.93 0.41
S. Creatinine (mg/dl) 2.14+0.63 2.28±0.75 2.13±0.61 2.10±0.71 0.52
Calcium (mg/dl) 8.86±0.88 9.03±0.77 8.68±1.19 8.85±0.70 0.41
Phosphorus (mg/dl) 4.27±0.74 4.28±0.64 4.40±0.90 4.28±0.64 0.92
e-GFR (ml/min) 34.37±11.84 32.55±10.41 34.80±13.02 35.80±12.02 0.49
Sodium (mmol/l) 138.49±4.22 138.73±3.84 138.30±3.99 138.35±4.92 0.93
Potassium (mmol/l) 4.38±0.56 4.43±0.64 4.40±0.59 4.38±0.59 0.95
SGOT (U/L) 24.33±11.25 22.30±9.15 23.30±6.82 42.58±104.01 0.58
SGPT (U/L) 23.35±13 20.23±10.48 22.65±8.73 41.38±97.18 0.06
T. Protein (gm/dl) 7.29±0.74 7.30±0.61 7.38±0.90 9.45±13.89 0.56
Albumin (gm/dl) 4.01±0.55 4.18±0.59 4.08±0.42 3.88±0.56 0.06
ALP (U/L) 94.75±39.90 92.15±38.38 96.60±34.39 95.58±46.76 0.45
iPTH (pg/ml) 321.78±301.56 269.33±178.19 269.50±160.91 288.15±167.14 0.75
FGF23(pg/ml) 17.86±23.28 16.13±13.44 18.15±27.12 19.35±27.03 0.77
X RAY Abdomen
Vascular calcification 1 (2.5%) 1 (2.5%) 1 (2.5%) 1.000 *
X RAY Chest
Vascular calcification 0.0% 1 (2.5%) 1 (2.5%) 0.795*
2 D Echocardiography 0.367*
LVH 13 (32.5%) 11 (27.5%) 7 (17.5%)
LVEF <60% 3 (7.5%) 7 (17.5%) 3 (7.5%)
Valvular calcification 2 (5.0%) 2 (5.0%) 1 (2.5%)

Data presented as mean±SD. Group 1- dietary phosphorus restriction, group 2- calcium based phosphate binders, group 3- non calcium based phosphate binders. BP: Blood Pressure; SGOT: serum glutamic oxaloacetictransaminasee; SGPT: serum glutamic pyruvic transaminase; ALP- alkaline phosphatase; iPTH: intact parathyroid hormone; FGF23: fibroblast growth factor 23, LVEF: left ventricular ejection fraction. Computed using KRUSKAL WALLIS TEST.